Live feed08:00:00·251dPRReleasevia QuantisnowTelitacicept Demonstrates Clinically Meaningful and Statistically Significant Impact on ESSDAI Compared to Placebo in Late-Breaking China Phase 3 Results in Primary Sjögren's Disease at ACR 2025ByQuantisnow·Wall Street's wire, on your screen.VOR· Vor Biopharma Inc.Health Care
